How to decrease the dose of Celexa (citalopram)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Decrease the Dose of Celexa (Citalopram)

When decreasing the dose of citalopram, a gradual reduction rather than abrupt cessation is strongly recommended to minimize withdrawal symptoms.

General Principles for Dose Reduction

  • Citalopram should be tapered gradually over 10-14 days to limit withdrawal symptoms 1
  • A gradual reduction in dose is preferred over abrupt discontinuation whenever possible 2
  • If intolerable symptoms occur during dose reduction, resuming the previously prescribed dose may be considered before attempting a more gradual taper 2

Specific Tapering Schedule

Standard Tapering Approach

  • For patients on 40 mg/day:

    • Reduce to 20 mg/day for 7-10 days 2
    • Then reduce to 10 mg/day for 7-10 days
    • Then discontinue
  • For patients on 20 mg/day:

    • Reduce to 10 mg/day for 7-10 days 2
    • Then discontinue

For Sensitive Populations

  • For elderly patients (>60 years), those with hepatic impairment, or CYP2C19 poor metabolizers:
    • Use more gradual tapering with smaller decrements 2
    • Consider longer intervals between dose reductions (2-3 weeks) 1

Monitoring During Dose Reduction

  • Monitor for discontinuation symptoms including:

    • Dizziness, fatigue, lethargy, general malaise, headaches 1
    • Nausea, vomiting, diarrhea, insomnia 1
    • Sensory disturbances, paresthesias, anxiety, irritability, and agitation 1
  • If withdrawal symptoms emerge:

    • Slow the rate of taper or temporarily return to the previous dose 2
    • Resume tapering at a more gradual rate once symptoms resolve 2

Special Considerations

  • Patients with severe renal impairment require more cautious dose reduction 2
  • Patients with a history of discontinuation symptoms may benefit from an even more gradual taper 1
  • For patients switching to another antidepressant, cross-tapering may be preferable to complete discontinuation 1

Common Pitfalls to Avoid

  • Avoid abrupt discontinuation which increases risk of withdrawal symptoms 2
  • Do not taper too quickly in elderly patients or those with hepatic impairment 2
  • Remember that citalopram's elimination half-life is about 27-33 hours, so steady-state concentrations take 7-10 days to achieve at each dose level 3
  • Be aware that some patients may require an even more gradual taper than the standard recommendation 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The clinical pharmacokinetics of escitalopram.

Clinical pharmacokinetics, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.